Exploring oral candidiasis among cancer patients undergoing chemotherapy in eastern Iran.

Abdol Sattar Pagheh, Fatemeh Kardan, Aynaz Ghojoghi, Ahmad Reza Sebzari, Maryam Erfaninejad, Parvin Askari, Seyed Reza Aghili, Eisa Nazar, Masood Ziaee
Author Information
  1. Abdol Sattar Pagheh: Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
  2. Fatemeh Kardan: Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
  3. Aynaz Ghojoghi: Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  4. Ahmad Reza Sebzari: Department of Internal Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
  5. Maryam Erfaninejad: Department of Basic Medical Sciences, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran.
  6. Parvin Askari: Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
  7. Seyed Reza Aghili: Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
  8. Eisa Nazar: Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
  9. Masood Ziaee: Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.

Abstract

Background and Objectives: Understanding the epidemiology of species among cancer patients is crucial for preventing invasive infections. This study aimed to identify species and assess risk factors among cancer patients receiving chemotherapy in Birjand, eastern Iran.
Materials and Methods: The samples were obtained from the oral cavity of 140 patients and the initial identification of species was carried out through fungal cultures. Subsequently, isolates were molecularly identified using the PCR-RFLP method with the restriction enzyme Msp1. Furthermore, the demographic characteristics, risk factors, and clinical history of the patients were extracted and scrutinized using a multiple logistic regression model.
Results: Among the 140 patients examined, 55 individuals (39.3%) tested positive for oral candidiasis (OC). Notably, Hemorrhagic cancer emerged as the most common type of cancer associated with OC (46.7%). The predominant species isolated was the complex (64.8%), followed by the complex (26.8%). A noteworthy finding was the significant association between the occurrence of OC and the number of chemotherapy sessions (P<0.05). Conversely, no significant correlations were detected between OC and variables such as sex, age, type of cancer, occupation, residence, underlying disease, and drug use (P>0.05).
Conclusion: The prevalence of spp. and its correlation with the number of chemotherapy sessions underscored the importance of preventive measures. These findings provided valuable insights for designing targeted interventions to mitigate the burden of oral candidiasis in this vulnerable population.

Keywords

References

  1. Curr Med Mycol. 2015 Dec;1(4):7-12 [PMID: 28680998]
  2. Anticancer Res. 2020 Sep;40(9):4819-4828 [PMID: 32878770]
  3. Cancer. 2004 Jan 15;100(2):228-37 [PMID: 14716755]
  4. iScience. 2022 Oct 10;25(11):105326 [PMID: 36325064]
  5. JAMA Oncol. 2015 Dec;1(9):1325-32 [PMID: 26270858]
  6. J Med Microbiol. 2020 May;69(5):712-720 [PMID: 32368996]
  7. Lett Appl Microbiol. 2018 Oct;67(4):392-399 [PMID: 30019443]
  8. Adv Biomed Res. 2020 Sep 30;9:50 [PMID: 33457333]
  9. Cancer Chemother Pharmacol. 2006 May;57(5):663-70 [PMID: 16133528]
  10. J Cell Mol Med. 2021 Aug;25(16):7948-7960 [PMID: 34155778]
  11. Iran J Microbiol. 2019 Apr;11(2):114-119 [PMID: 31341565]
  12. Arch Oral Biol. 2020 Nov;119:104906 [PMID: 32947164]
  13. Sci Rep. 2024 Jan 22;14(1):1906 [PMID: 38253731]
  14. J Oral Maxillofac Surg. 2011 Apr;69(4):1207-13 [PMID: 20691530]
  15. Liver Int. 2022 Oct;42(10):2299-2316 [PMID: 35779247]
  16. J Clin Exp Dent. 2014 Feb 01;6(1):e81-90 [PMID: 24596641]
  17. J Mycol Med. 2019 Sep;29(3):223-232 [PMID: 31235209]
  18. Nihon Ishinkin Gakkai Zasshi. 2006;47(3):225-9 [PMID: 16940958]
  19. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Mar;115(3):354-8 [PMID: 23312542]
  20. Braz J Microbiol. 2023 Mar;54(1):143-149 [PMID: 36378415]
  21. Eukaryot Cell. 2014 Aug;13(8):958-64 [PMID: 24951439]
  22. Front Pediatr. 2021 Dec 24;9:805527 [PMID: 35004551]
  23. Oral Oncol. 2015 Feb;51(2):139-45 [PMID: 25498921]
  24. Expert Opin Pharmacother. 2011 Apr;12(6):851-63 [PMID: 21254862]
  25. Trends Microbiol. 2014 Mar;22(3):120-7 [PMID: 24530175]
  26. Lancet Infect Dis. 2015 Dec;15(12):1429-37 [PMID: 26482597]
  27. Support Care Cancer. 2010 Aug;18(8):985-92 [PMID: 20449755]
  28. Clin Infect Dis. 2010 Sep 1;51(5):e38-45 [PMID: 20636126]

Word Cloud

Created with Highcharts 10.0.0cancerpatientsspecieschemotherapyoralOCamongfactorscandidiasisriskeasternIran140usingtypecomplex8%significantnumbersessions05BackgroundObjectives:UnderstandingepidemiologycrucialpreventinginvasiveinfectionsstudyaimedidentifyassessreceivingBirjandMaterialsMethods:samplesobtainedcavityinitialidentificationcarriedfungalculturesSubsequentlyisolatesmolecularlyidentifiedPCR-RFLPmethodrestrictionenzymeMsp1FurthermoredemographiccharacteristicsclinicalhistoryextractedscrutinizedmultiplelogisticregressionmodelResults:Amongexamined55individuals393%testedpositiveNotablyHemorrhagicemergedcommonassociated467%predominantisolated64followed26noteworthyfindingassociationoccurrenceP<0ConverselycorrelationsdetectedvariablessexageoccupationresidenceunderlyingdiseasedruguseP>0Conclusion:prevalencesppcorrelationunderscoredimportancepreventivemeasuresfindingsprovidedvaluableinsightsdesigningtargetedinterventionsmitigateburdenvulnerablepopulationExploringundergoingCandidaCandidiasisChemotherapyadjuvantEpidemiologyNeoplasmsRisk

Similar Articles

Cited By

No available data.